Prostate Cancer: Palliative treatment of metastatic or locally advanced prostate cancer , where suitable for hormonal manipulation. Adjuvant and neo-adjuvant therapy in combination with radiotherapy for the management of locally advanced prostate cancer in men suitable for hormonal manipulation.
How to take it
The way to take this medicine is: Subcutaneous.
This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
Shelf lifetime is 0 .
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to cream coloured cylindrical pieces of rigid polymeric material which are free or practically free from visible impurities.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prostate Cancer: Palliative treatment of metastatic or locally advanced prostate cancer, where suitable for hormonal manipulation. Adjuvant and neo-adjuvant therapy in combination with radiotherapy for the management of locally advanced prostate cancer in men suitable for hormonal manipulation. Breast Cancer: Treatment of advanced breast cancer (T3b, T4 or any T with N2, 3 or M plus) in premenopausal women suitable for hormonal manipulation. Adjuvant therapy in early breast cancer, in pre- and perimenopausal women suitable for hormonal manipulation. Endometriosis: In the management of visually proven endometriosis to reduce symptoms including pain and the size and number of endometrial lesions. Uterine Fibroids: In the management of fibroids, ASTRAZENECA GOSERELIN shrinks the lesions and reduces the symptoms, including pain. ASTRAZENECA GOSERELIN also increases the haemoglobin concentration and haematocrit in women with anaemia attributable to menorrhagia. It is used as an adjunct to surgery to facilitate the operative technique and reduce operativeblood loss. Endometrial Thinning: Use as an endometrial thinning agent prior to endometrial ablation. Assisted Reproduction: Pituitary down regulation in preparation for controlled ovarian superstimulation.
How to take it
The way to take this medicine is: Subcutaneous.
This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Shelf lifetime is 0 .
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White to cream-coloured cylindrical pieces of rigid polymeric material.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.